stockrowNu Skin Enterprises, Inc.
NUS Consumer Defensive Household & Personal Products
Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024.
- Revenue
- −17.1%
- EPS
- −1,295.4%
- Free cash flow
- −86.1%
- Total debt
- −14.2%
Quarter to June 2026, against a year earlier
Follow NUS
Alert me
Nu Skin Enterprises, Inc. (NUS) EV/Sales
As of 2 November 2026, Nu Skin Enterprises, Inc. (NUS) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.2× (September 2026) to 1.9× (June 2018); the current reading is higher than 1% of that period. That is below the Household & Personal Products industry median of 1.2× and below the Consumer Defensive sector median of 1.0×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.3× | (0.55%) |
| FY2024 | 0.3× | (50.90%) |
| FY2023 | 0.6× | (37.07%) |
| FY2022 | 1.0× | 5.46% |
| FY2021 | 1.0× | (11.13%) |
| FY2020 | 1.1× | 13.17% |
| FY2019 | 0.9× | (25.69%) |
| FY2018 | 1.3× | (18.62%) |
| FY2017 | 1.6× | 25.73% |
| FY2016 | 1.2× | 30.63% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.2× | (21.88%) |
| Mar 2026 | 0.3× | (15.93%) |
| Dec 2025 | 0.3× | (16.68%) |
| Sep 2025 | 0.4× | 59.19% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| YSG Yatsen Holding Limited Sponsored ADR compare | 0.1× |
| NUS Nu Skin Enterprises, Inc. | 0.2× |
| MAGN Magnera Corporation compare | 0.6× |
| SKIN SkinHealth Systems Inc. compare | 0.7× |
| HELE Helen of Troy Limited compare | 0.7× |
| HNST The Honest Company, Inc. compare | 1.2× |
| ACU Acme United Corporation. compare | 1.4× |
| SLSN Solesence, Inc. compare | 1.5× |
| ODD ODDITY Tech Ltd. compare | 2.0× |
| Household & Personal Products industry median | 1.2× |
| Consumer Defensive sector median | 1.0× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)